The scientist’s investigation covers issues in Immunology, Internal medicine, Cohort study, Acquired immunodeficiency syndrome and Viral load. The study incorporates disciplines such as Disease, Cohort and Virology in addition to Immunology. His Internal medicine study incorporates themes from Gastroenterology, Surgery and Ritonavir.
Matthias Cavassini interconnects Life expectancy, Confidence interval and Antiretroviral therapy in the investigation of issues within Cohort study. His Acquired immunodeficiency syndrome research is multidisciplinary, incorporating perspectives in Viral disease, Logistic regression and Essential hypertension. His Viral load research incorporates elements of Regimen, Adverse effect, Pharmacology, Randomized controlled trial and Lamivudine.
Matthias Cavassini focuses on Internal medicine, Cohort study, Immunology, Viral load and Acquired immunodeficiency syndrome. His study in Internal medicine is interdisciplinary in nature, drawing from both Gastroenterology, Surgery and Oncology. In his research, Pediatrics is intimately related to Cohort, which falls under the overarching field of Cohort study.
His study in Immunology is interdisciplinary in nature, drawing from both Antiretroviral therapy and Virology. His work focuses on many connections between Viral load and other disciplines, such as Lamivudine, that overlap with his field of interest in Zidovudine and Efavirenz. A large part of his Acquired immunodeficiency syndrome studies is devoted to Sida.
His primary areas of study are Cohort study, Internal medicine, Cohort, Men who have sex with men and Viral load. His Cohort study research incorporates themes from Tenofovir alafenamide, Epidemiology, Confidence interval, Neurocognitive and Prospective cohort study. His studies in Internal medicine integrate themes in fields like Dolutegravir and Oncology.
His work deals with themes such as Mortality rate, Logistic regression and Renal function, which intersect with Cohort. Viral load is a subfield of Immunology that Matthias Cavassini investigates. Matthias Cavassini has included themes like Genetic variation and Genetic association in his Immunology study.
Matthias Cavassini mainly investigates Internal medicine, Cohort study, Cell, Cohort and Men who have sex with men. He has researched Internal medicine in several fields, including Dolutegravir and Lamivudine. Matthias Cavassini combines subjects such as Prospective cohort study, Drug and Geriatrics with his study of Cohort study.
His Cohort research integrates issues from Neurocognitive and Darunavir. Matthias Cavassini focuses mostly in the field of Antiretroviral therapy, narrowing it down to topics relating to Population level and, in certain cases, Viral load. His studies examine the connections between Lymph and genetics, as well as such issues in Stem cell marker, with regards to Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia.
Samanta Simioni;Matthias Cavassini;Jean Marie Annoni;Aline Rimbault Abraham.
AIDS (2009)
Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study
Barbara Hasse;Bruno Ledergerber;Hansjakob Furrer;Manuel Battegay.
Clinical Infectious Diseases (2011)
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Adam Trickey;Margaret T May;Jorg-Janne Vehreschild;Niels Obel.
The Lancet HIV (2017)
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin.
Clinical Infectious Diseases (2005)
Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study
R Weber;M Ruppik;M Rickenbach;A Spoerri.
Hiv Medicine (2013)
Dominant TNF-α + Mycobacterium tuberculosis –specific CD4 + T cell responses discriminate between latent infection and active disease
Alexandre Harari;Virginie Rozot;Felicitas Bellutti Enders;Matthieu Perreau.
Nature Medicine (2011)
PD-1 + and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals
Riddhima Banga;Francesco Andrea Procopio;Alessandra Noto;Georgios Pollakis.
Nature Medicine (2016)
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
S. Franceschi;M. Lise;G. M. Clifford;M. Rickenbach.
British Journal of Cancer (2010)
Predictive Value of Known and Novel Alleles of CYP2B6 for Efavirenz Plasma Concentrations in HIV‐infected Individuals
M Rotger;H Tegude;S Colombo;M Cavassini.
Clinical Pharmacology & Therapeutics (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Universita della Svizzera Italiana
University of Bern
University Hospital of Basel
University of Zurich
University of St. Gallen
Geneva College
University of Zurich
University of Zurich
University of Zurich
University of Basel
King Abdullah University of Science and Technology
Tohoku University
Stanford University
Central European Institute of Technology
Temple University
University of Toyama
Arizona State University
University of Science and Technology of China
Center for Research in Agricultural Genomics
British Trust for Ornithology
University of North Texas
Johns Hopkins University
McGill University
George Washington University
Kyushu University
Medical University of South Carolina